Perspective Therapeutics, Inc. is a biotech company pioneering innovative cancer treatments using cesium-131 brachytherapy seeds and lead-212 technology, with promising clinical trial data and a focus on delivering cutting-edge treatments.

Perspective Therapeutics, a biotech company, is pioneering innovative cancer treatments using alpha radiation and targeted peptides, with its stock price experiencing significant fluctuations amidst a complex valuation landscape.